Stocks
GlaxoSmithKline (GSK) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 7.70% | 7.70% | 7.70% | 7.73% | 7.73% | 8.60% | |||
| Changes by years, y/y, % | -1pp | 0pp | 0pp | +0pp | 0pp | +5.8% | |||
GlaxoSmithKline. CAPEX/Revenue, %
GlaxoSmithKline. CAPEX/Revenue, changes, pp
GlaxoSmithKline (GSK) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 7.65% | 5.61% | 5.61% | 10.5% | 10.5% | 8.60% | ||
| Changes by years, y/y, % | +0pp | -2pp | -2pp | +4pp | +4pp | |||
| Changes by quarters, q/q, % | -2pp | -2pp | 0pp | +5pp | 0pp | |||
